Summit Therapeutics Inc. (SMMT) NASDAQ
14.84
-0.23(-1.53%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.84
-0.23(-1.53%)
Currency In USD
| Market Cap | 13.08B |
| Enterprise Value | 12.93B |
| P/E Ratio | -10.93 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 27.8 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.79 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.14 |
| Return On Equity | -3.41 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -1.08B |
| Net Income | -1.08B |
| Diluted EPS | -1.44 |
| Total Cash | 454.05M |
| Total Cash/Share | 0.59 |
| Total Debt | 15.2M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 7.41 |
| Book Value Per Share | 0.53 |
| 52-Week Change | -24.13 |
| 52-Week High | 30.98 |
| 52-Week Low | 13.83 |
| Moving Average 50 Days | 18.98 |
| Moving Average 200 Days | 18.59 |
| Average Volume | 4.13M |
| Shares Outstanding | 775.37M |
| % Held by Institutions | 15.9 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |